Progyny

Progyny EBIT Margin

The EBIT Margin (Operating Margin) of Progyny (PGNY) as of Oct 29, 2026 is 6.62 %. In the previous year, EBIT Margin (Operating Margin) was 5.78 % — a change of 14.51% (higher).

EBIT Margin

6.62 %

YoY

14.51%

Last updated:

EBIT Margin (Operating Margin) of Progyny is 2025 6.62 % . EBIT Margin (Operating Margin) of Progyny was 2024 5.78 % . It decreases by 14.51% higher compared to the previous year.

For Progyny, the operating (EBIT) margin of 6.6% is broadly stable versus 6.5% a few years ago.

The Progyny EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-6.07 USD
Jan 1, 2019
4.21 USD
Jan 1, 2020
2.42 USD
Jan 1, 2021
6.46 USD
Jan 1, 2022
2.97 USD
Jan 1, 2023
5.71 USD
Jan 1, 2024
5.78 USD
Jan 1, 2025
6.62 USD
The Progyny EBIT Margin history
YEAREBIT MarginYoY
6.62 %+14.51%
5.78 %+1.17%
5.71 %+92.58%
2.97 %-54.08%
6.46 %+166.86%
2.42 %-42.54%
4.21 %-169.43%
-6.07 %-74.84%
-24.12 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Progyny Stock analysis

What does Progyny do? Progyny Inc. is a company specializing in reproductive medicine and fertility treatments. It was founded in New York City in 2008 and has been listed on the NASDAQ stock exchange since 2019. The idea for Progyny arose when founder Gina Bartasi herself had difficulty getting pregnant and was searching for support and transparent information. She recognized the need to offer a better and more accessible service for people with fertility problems, thus founding Progyny. Progyny's business model is to offer employers a fertility benefit to help their employees, especially women, with family planning. It provides customized fertility treatments and financial assistance through its innovative programs. This allows employers to position themselves as progressive and inclusive while also increasing the bond and well-being of their employees. The different divisions of Progyny include fertility management, fertility measurement and monitoring, and fertility benefits. The fertility management solutions provide companies with comprehensive care for their employees, including counseling and support on fertility and family planning. They also provide access to an exclusive network practice specializing in reproductive medicine, including in vitro fertilization (IVF) and egg donation. The fertility measurement and monitoring program offers a personalized fertility profile that allows employees to track their fertility status to maximize their chances of a successful pregnancy. Progyny utilizes advanced methods of artificial intelligence and machine learning for this purpose. Progyny's fertility benefits include financial support for fertility treatments and medications that are not normally covered by health insurance. Additionally, the company offers a unique membership option that provides unlimited access to master fertility practices for one year. Progyny also offers a comprehensive patient experience through world-leading doctors and a patented technology platform. The platform provides support in navigating the fertility process and ensures that patients receive the best possible medical and financial care. Overall, Progyny has a significant impact on the field of reproductive medicine. With an innovative solution tailored to the needs of employers and strong support for aspiring parents, the company achieves a higher success rate in pregnancy compared to traditional fertility treatments. Progyny's technology platform improves workflow efficiency and communication in the practice, leading to a better patient experience and greater engagement. Overall, Progyny offers a holistic solution for employers and employees tailored to the unique challenges of family planning and fertility. With innovative approaches and a focus on the well-being of female employees, the company has taken a unique position in the market and is expected to continue to play a strong role in the industry. Progyny is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Progyny stock

EBIT Margin (Operating Margin) of Progyny is 6.62 % in 2025.

EBIT Margin (Operating Margin) of Progyny changed from 5.78 % to 6.62 %, representing a 14.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Progyny since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Progyny with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Progyny

All Key Metrics — Progyny